Drug Type Antibody drug conjugate (ADC) |
Synonyms IMD 2329, IMD2329 |
Action inhibitors, agonists |
Mechanism CD276 inhibitors(CD276 antigen inhibitors), DLL3 inhibitors(Delta-like protein 3 inhibitors), TLR7 agonists(Toll like receptor 7 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC26H24FN3O6 |
InChIKeyPLXLYXLUCNZSAA-QLXKLKPCSA-N |
CAS Registry1599440-33-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | China | 07 Apr 2024 |